Pediatric Neurology
Volume 42, Issue 2 , Pages 77-85, February 2010

Postural Orthostatic Tachycardia Syndrome: A Clinical Review

  • Jonathan N. Johnson, MD

      Affiliations

    • Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationCommunications should be addressed to: Dr. Johnson; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine; Mayo Clinic; Gonda 6 South; 200 First Street Southwest; Rochester, MN 55905.
  • ,
  • Kenneth J. Mack, MD, PhD

      Affiliations

    • Division of Child Neurology, Department of Neurology and Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Nancy L. Kuntz, MD

      Affiliations

    • Division of Child Neurology, Department of Neurology and Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Chad K. Brands, MD

      Affiliations

    • Division of General Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Coburn J. Porter, MD

      Affiliations

    • Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Philip R. Fischer, MD

      Affiliations

    • Division of General Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota

Received 29 January 2009; accepted 6 July 2009.

Postural orthostatic tachycardia syndrome was defined in adult patients as an increase >30 beats per minute in heart rate of a symptomatic patient when moving from supine to upright position. Clinical signs may include postural tachycardia, headache, abdominal discomfort, dizziness/presyncope, nausea, and fatigue. The most common adolescent presentation involves teenagers within 1-3 years of their growth spurt who, after a period of inactivity from illness or injury, cannot return to normal activity levels because of symptoms induced by upright posture. Postural orthostatic tachycardia syndrome is complex and likely has numerous, concurrent pathophysiologic etiologies, presenting along a wide spectrum of potential symptoms. Nonpharmacologic treatment includes (1) increasing aerobic exercise, (2) lower-extremity strengthening, (3) increasing fluid/salt intake, (4) psychophysiologic training for management of pain/anxiety, and (5) family education. Pharmacologic treatment is recommended on a case-by-case basis, and can include β-blocking agents to blunt orthostatic increases in heart rate, α-adrenergic agents to increase peripheral vascular resistance, mineralocorticoid agents to increase blood volume, and serotonin reuptake inhibitors. An interdisciplinary research approach may determine mechanistic root causes of symptoms, and is investigating novel management plans for affected patients.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(09)00345-2

doi:10.1016/j.pediatrneurol.2009.07.002

Pediatric Neurology
Volume 42, Issue 2 , Pages 77-85, February 2010